OR52D1

Across TCGA pan-cancer cohorts, OR52D1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR52D1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where OR52D1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR52D1 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

BLCA and LUAD are the cancer types where OR52D1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52D1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	III,IV	+0.058	.025	1	view →
LUAD	All	III,IV	−0.034	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

OR52D1–BLCA

Open the BLCA breakdown →